Harvey A Risch1, Lingeng Lu, Mark S Kidd, Jing Wang, Wei Zhang, Quanxing Ni, Yu-Tang Gao, Herbert Yu. 1. Authors' Affiliations: Department of Chronic Disease Epidemiology, Yale School of Public Health; Department of Surgery, Yale School of Medicine, New Haven, Connecticut; Department of Epidemiology, Shanghai Cancer Institute, Jiao Tong University; Department of Pancreas and Hepatobiliary Surgery, Shanghai Medical College, Fudan University, Shanghai, China; and Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Abstract
BACKGROUND: Pathophysiologic actions of Helicobacter pylori colonization on gastric acidity have been hypothesized to modulate the effect of pancreatic carcinogens, through CagA-negative organism strain type, hyperchlorhydria and increased risk of pancreatic cancer, or CagA-positive strain, hypochlorhydria and decreased risk of pancreatic cancer. We aimed to determine H. pylori strain-specific associations with pancreatic cancer in a population in which colonization by CagA-positive strains is common. METHODS: We carried out a large population-based case-control study of pancreatic carcinoma in Shanghai, China. Venipuncture specimens were obtained from a representative sample of 761 case patients and 794 randomly selected control subjects matched by category of age and gender. Antibody seropositivity for H. pylori and its virulence protein CagA were determined by commercial enzyme-linked immunosorbent IgG assays. RESULTS: Compared with individuals seronegative for both H. pylori and CagA, decreased pancreas-cancer risk was seen for CagA seropositivity [adjusted OR, 0.68; 95% confidence interval (CI), 0.54-0.84], whereas some increased risk was suggested for CagA-negative H. pylori seropositivity (OR, 1.28; 95% CI, 0.76-2.13). No risk interactions were observed between CagA seropositivity and gender, cigarette smoking, or age-21 body mass index. CONCLUSIONS: Similar to what has been seen in animal models, our results provide suggestive evidence in humans for the involvement of gastric acidity, through its bidirectional modification according to colonization by H. pylori CagA strain type, in the risk of pancreatic carcinoma. IMPACT: H. pylori colonization may have diverse effects on cancer risk, depending on the organism strain type as well as on the particular cancer site.
BACKGROUND: Pathophysiologic actions of Helicobacter pylori colonization on gastric acidity have been hypothesized to modulate the effect of pancreatic carcinogens, through CagA-negative organism strain type, hyperchlorhydria and increased risk of pancreatic cancer, or CagA-positive strain, hypochlorhydria and decreased risk of pancreatic cancer. We aimed to determine H. pylori strain-specific associations with pancreatic cancer in a population in which colonization by CagA-positive strains is common. METHODS: We carried out a large population-based case-control study of pancreatic carcinoma in Shanghai, China. Venipuncture specimens were obtained from a representative sample of 761 case patients and 794 randomly selected control subjects matched by category of age and gender. Antibody seropositivity for H. pylori and its virulence protein CagA were determined by commercial enzyme-linked immunosorbent IgG assays. RESULTS: Compared with individuals seronegative for both H. pylori and CagA, decreased pancreas-cancer risk was seen for CagA seropositivity [adjusted OR, 0.68; 95% confidence interval (CI), 0.54-0.84], whereas some increased risk was suggested for CagA-negative H. pylori seropositivity (OR, 1.28; 95% CI, 0.76-2.13). No risk interactions were observed between CagA seropositivity and gender, cigarette smoking, or age-21 body mass index. CONCLUSIONS: Similar to what has been seen in animal models, our results provide suggestive evidence in humans for the involvement of gastric acidity, through its bidirectional modification according to colonization by H. pylori CagA strain type, in the risk of pancreatic carcinoma. IMPACT: H. pylori colonization may have diverse effects on cancer risk, depending on the organism strain type as well as on the particular cancer site.
Authors: C Di Campli; R Nocente; G Costamagna; N Gentiloni; R Burioni; J Wu; A Armuzzi; M A Zern; G Gasbarrini; A Gasbarrini Journal: Int J Pancreatol Date: 2000-12
Authors: Timo U Kosunen; Eero Pukkala; Seppo Sarna; Kari Seppälä; Arpo Aromaa; Paul Knekt; Hilpi Rautelin Journal: Int J Cancer Date: 2010-03-22 Impact factor: 7.396
Authors: T Kumagai; H M Malaty; D Y Graham; S Hosogaya; K Misawa; K Furihata; H Ota; C Sei; E Tanaka; T Akamatsu; T Shimizu; K Kiyosawa; T Katsuyama Journal: J Infect Dis Date: 1998-09 Impact factor: 5.226
Authors: Catherine de Martel; Augusto E Llosa; Gary D Friedman; Gary D Friedmana; Joseph H Vogelman; Norman Orentreich; Rachael Z Stolzenberg-Solomon; Julie Parsonnet Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-05 Impact factor: 4.254
Authors: Leila Lujan-Barroso; Wei Zhang; Sara H Olson; Yu-Tang Gao; Herbert Yu; Peter A Baghurst; Paige M Bracci; H Bas Bueno-de-Mesquita; Lenka Foretová; Steven Gallinger; Ivana Holcatova; Vladimír Janout; Bu-Tian Ji; Robert C Kurtz; Carlo La Vecchia; Pagona Lagiou; Donghui Li; Anthony B Miller; Diego Serraino; Witold Zatonski; Harvey A Risch; Eric J Duell Journal: Pancreas Date: 2016-11 Impact factor: 3.327
Authors: Jiaqi Huang; Ulrika Zagai; Göran Hallmans; Olof Nyrén; Lars Engstrand; Rachael Stolzenberg-Solomon; Eric J Duell; Kim Overvad; Verena A Katzke; Rudolf Kaaks; Mazda Jenab; Jin Young Park; Raul Murillo; Antonia Trichopoulou; Pagona Lagiou; Christina Bamia; Kathryn E Bradbury; Elio Riboli; Dagfinn Aune; Konstantinos K Tsilidis; Gabriel Capellá; Antonio Agudo; Vittorio Krogh; Domenico Palli; Salvatore Panico; Elisabete Weiderpass; Anne Tjønneland; Anja Olsen; Begoña Martínez; Daniel Redondo-Sanchez; Maria-Dolores Chirlaque; Petra Hm Peeters; Sara Regnér; Björn Lindkvist; Alessio Naccarati; Eva Ardanaz; Nerea Larrañaga; Marie-Christine Boutron-Ruault; Vinciane Rebours; Amélie Barré; H B As Bueno-de-Mesquita; Weimin Ye Journal: Int J Cancer Date: 2017-04-15 Impact factor: 7.396
Authors: María Fernanda González; Paula Díaz; Alejandra Sandoval-Bórquez; Daniela Herrera; Andrew F G Quest Journal: Int J Mol Sci Date: 2021-05-01 Impact factor: 5.923
Authors: Camila Leal-Lopes; Fernando J Velloso; Julia C Campopiano; Mari C Sogayar; Ricardo G Correa Journal: J Diabetes Res Date: 2015-08-06 Impact factor: 4.011
Authors: Xin-Zu Chen; Ben Schöttker; Felipe Andres Castro; Hongda Chen; Yan Zhang; Bernd Holleczek; Hermann Brenner Journal: Oncotarget Date: 2016-03-29